28 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
one post - baseline total SOFA score. 2 - Acute Physiology and Chronic Health Evaluation (APACHE) II is an ICU score system, used to determine
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
mechanism of action to resolve chronic low grade inflammation of joints with osteoarthritis, as well as a substantial recovery in a case of a 70-year old … in osteoarthritis followed preclinical evidence of the potential applicability of Allocetra’sTM mechanism of action to resolve chronic low grade
6-K
ENLV
Enlivex Therapeutics Ltd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
of Allocetra’sTM mechanism of action to resolve chronic low grade inflammation of joints with osteoarthritis, as well as a substantial recovery in a case
6-K
EX-99.1
nlf abmwhui4abn
3 Feb 21
Current Report
7:55am
6-K
EX-99.1
5e0z9tjaneov
21 Dec 20
Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv
8:02am
6-K
EX-99.1
hoc qpnp4y6pc
3 Dec 20
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:00am
6-K
EX-99.1
jyo7dp3lf 1fzkt
18 Nov 20
Enlivex Reports Positive Two-Year Clinical Outcome For A Hospitalized Patient with Erosive Osteoarthritis Treated with Allocetra
8:02am
6-K
EX-99.1
jw4soze1t1 epxyk
3 Nov 20
Current report (foreign)
9:14am
6-K
EX-99.1
7nd25yl78wnrz
27 Oct 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
n9091g
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
6-K
EX-99.1
ctkr2s
13 Oct 20
Report of Foreign Private Issuer
9:30am
6-K
EX-99.1
kksj221
18 Mar 20
Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
8:26am
20-F/A
73y tllbm35z301c
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
rknax 868d
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
tf85m
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm